Humana Inc

Latest Results (14.08.2024):

Revenue Growth

Humana Inc. reported revenues of $29.54 billion for the second quarter of 2024, an increase from $26.75 billion in the same quarter of 2023. Year-to-date revenues for 2024 reached $59.15 billion, up from $53.49 billion in the first half of 2023. This growth reflects the company's strong performance and expanding market presence.

Earnings Per Share

For the second quarter of 2024, Humana Inc. reported diluted earnings per share (EPS) of $5.62 on a GAAP basis, compared to $7.66 in the second quarter of 2023. On an adjusted basis, the EPS was $6.96, down from $8.94 in the same period last year. Year-to-date GAAP EPS for 2024 was $11.74, with an adjusted EPS of $14.19.

Operating Income

Humana Inc.'s consolidated income before income taxes for the second quarter of 2024 was $918 million, compared to $1.26 billion in the second quarter of 2023. On an adjusted basis, the pretax income was $1.13 billion, down from $1.47 billion in the same period last year. Year-to-date pretax income for 2024 was $1.93 billion, with an adjusted figure of $2.32 billion.

Membership Growth

Humana Inc. raised its 2024 individual Medicare Advantage annual membership growth forecast by 75,000, now anticipating an annual growth of approximately 225,000 members, or 4.2 percent. This adjustment reflects the company's successful efforts in expanding its Medicare Advantage offerings and attracting new members.

FY 2024 Guidance

Humana Inc. revised its full-year 2024 GAAP EPS guidance to approximately $12.81, down from the previous estimate of $13.93. However, the company affirmed its adjusted EPS guidance of approximately $16.00 for the year. This outlook underscores Humana's confidence in its core business operations despite the revised GAAP expectations.